Unlike CT, which produces a volumetric rendering of the brain with little more than the push of a button, MR requires considerable fiddling.
Unlike CT, which produces a volumetric rendering of the brain with little more than the push of a button, MR requires considerable fiddling.
"People have referred to MR as the science experiment that escaped from the lab," said Dave Ferguson, general manager of core products for GE Healthcare's MR business. "There are a lot of error paths available to the technologist."
Ferguson would like to get around that by leveraging the technologies that so far have made MR more difficult. New gradients and increased channel count have increased MR speed and expanded clinical applications, but they have also made the modality more complex and difficult to operate. But those technologies could also make MR easier to use, he said.
"This is as important for the proliferation of MR globally and in the U.S. as any single breakthrough clinical application," Ferguson said.
Higher channel counts coupled with parallel imaging, to date used to increase scan speed, might also enable ease of use. The immediate focus would be on image quality, which would translate into fewer repeat scans.
Another enabler of improved ease of use is the development of motion insensitive imaging techniques. An early example is GE's Propeller, whose radial acquisition of data sprays artifacts out of the volume rather than through it. Other MR vendors have followed suit with similar techniques designed to reduce the effect of motion on image quality. The ultimate goal now at GE is to develop techniques that make every image diagnostic.
"When we launched Propeller, it opened our eyes to how important motion insensitive imaging can be," Ferguson said. "So there will be more things like that. They will be part of our product portfolio in the coming one to two years."
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.